Moving Discoveries from the lab to the clinic
Mission
To foster the translation of UF Health Cancer Institute member discoveries through a comprehensive, structured and efficient review and prioritization process.
Overview
The UF Health Cancer Institute recognizes the importance of providing structure and support for the translational pathway to facilitate and expedite the movement of discoveries made by our research members from the laboratory into the clinics for the benefit of our patients. To accomplish this goal, there must be a well-defined, transparent and high-quality mechanism for review, identification and prioritization of discoveries that have future clinical application. The Translational Research Council (TRC) serves as the body to enable this process.
The TRC supports the UF Health Cancer Institute ‘s research enterprise by bringing together an engaged coalition of internal and external stakeholders involved in research strategy, with the primary goal of helping prioritize and facilitate the translation of UF member discoveries to clinical application. The council provides broad scientific and programmatic advice on the strategic investment of UF Health Cancer Institute funds and institutional resources to bring new discoveries out of the labs and into well-designed clinical trials.
Data Sources
The council builds cross-college collaborations on all levels to assist in identifying even the earliest concepts with the potential to be guided into translation within the scope of the UF Health Cancer Institute. The council also uses a broad range of resources available to the Cancer Institute, streamlining the review of IND, IDE, patent and license agreement data to capture early-stage translational discoveries, provide guidance to investigators and facilitate advancement within the translational pathway.
Translational Discovery Pathway & Dashboard
The TRC has answered the charge to create a structured translational pathway by bringing together subject matter experts and core offices across campus building a network to streamline the translational process, and through construction of a comprehensive electronic dashboard. This cutting-edge dashboard provides the council with the unique ability to filter a library of translational discoveries by investigator, translation stage and disease site, as well as the ability to track discovery advancement and TRC effort, paving the way for the future of translational research.
What can the TRC do for you?
To schedule a free consultation, please submit your concept or discovery using the form below, or reach out to the Research Development Team for assistance.
TRC Leadership
Council Members
Jonathan D Licht M.D.
Thomas J George M.D., F.A.C.P., F.A.S.C.O.
Duane A Mitchell M.D., Ph.D.
Rolf Renne
Paul L Crispen M.D.
Alison M Ivey RN, MS, MBA, OCN, CCRP
Erin H Monari PhD, CCRP
Dejana Braithwaite, PhD, MSc
Ramzi G Salloum Ph.D.
Jennifer N Woodard
Stephanie Staras Ph.D.
Christian Jobin Ph.D.
Elias Sayour MD, PhD
Jatinder Lamba Ph.D., M.Sc.
Timothy P Spicer Ph.D.
Ad Hoc Members
- Jim O’Connell (AVP, UF Innovate)
- Michael Mahoney (Director of Research Operations & Services, UF Research)
- Amber Moore (Deputy Director, Deputy Research Integrity Officer & COI Administrator, UF Research)
- Anita Rao (Program Director, Pathways, UF Innovate)
- Blank Sharma, Ph.D. (IOM research program, Associate Professor of Biomedical Engineering)
- Carlos Rinaldi-Ramos, Ph.D. (IOM research program, Professor of Chemical Engineering)
- Ji-Hyun Lee, DrPH (CCPS research program, Professor of Biostatistics)
- Anna Kukulka (Assistant Director, Experimental Therapeutics & Cellular Therapies, Clinical Research Office)
- Nina McGrew (Assistant Director, Project Management & Network Operations​, Project Management Office)
Research Administration Contact
